The biotechnological studies when developing lozenges with probiotics
Keywords:probiotic, lozenges, ENT diseases
Aim. To develop lozenges with probiotic components for the treatment and prevention of ENT diseases and analyze their effectiveness.
Materials and methods. The study objects were lozenges based on xylitol and sorbitol of two compositions – based on live probiotic cultures and their metabolites. The following methods of control of the sample efficiency were
chosen: determination of the number of viable lactobacilli in the study of their combined use with the drug components and the number of viable bacteria in finished oral probiotics by the Koch method (direct seeding on cups), as well as the method of diffusion into agar with the growth inhibition zone determination.
Results and discussion. The studies of the properties of probiotic strains of L. fermentum 90-TC and L plantarum 8P-A3 have shown the prospects for their use in oral probiotics. It has been also proposed to use metabolites
of these strains as active components, which have a rather high antimicrobial potential to opportunistic pathogens that cause infectious ENT diseases. The oral probiotics in the form of lozenges of two compositions – based on live lactobacilli and their metabolites – have shown high efficiency, bacterial survival and antimicrobial properties, respectively.
Conclusions. During the complex of the theoretical, technological and biotechnological studies, lozenges with a probiotic of two compositions (based on viable probiotic cultures and their metabolites) have been developed. After further research they can be recommended as a biologically active additive to support the oral microflora, stimulate the own immunity and as a therapeutic and prophylactic agent in infectious diseases of the oral cavity for use in both adults and children.
1. Sanders, M. E., Merenstein, D., Merrifield, C. A., Hutkins, R. (2018). Probiotics for human use. Nutrition Bulletin, Aug 10. doi: https://doi.org/10.1111/nbu.12334.
2. Food and Agricultural Organization/WHO. (2002). Guidelines for the evaluation of probiotics in food. In: Report of a Joint FAO/WHO Working Group on Drafting Guidelines for the Evaluation of Probiotics in Food. Rome, Italy. Available at: https://www.who.int/foodsafety/fs_management/en/probiotic_guidelines.pdf.
3. Gao, L., Xu, T., Huang, G., Jiang, S., Gu, Y., Chen, F. (2018). Oral microbiomes: more and more importance in oral cavity and whole body. Protein Cell, 9, 488–500. doi: 10.1007/s13238-018-0548-1.
4. Еxpanded Human Oral Microbiome Database. Available at: http://www.homd.org/.
5. Andreeva, I. V., Stecziuk, O. U. (2019). Klinicheskaia mikrobiolohiia i antimikrobnaia khimioterapiia, 21 (2), 92–99. doi: 10.36488/cmac.2019.2.92-99.
6. Kriuchko, T. O., Tkachenko, O. Ya. (2018). Zdorove rebenka, 13 (7), 629–634. doi: https://doi.org/10.22141/2224-05126.96.36.1998.148915.
7. Lezhenko, H. O., Pashkova, O. Ye. (2016). Sovremennaia pediatriia, 1 (73), 44–48.
8. Hodovana, O. I., Bezhuk, Yu. A. (2019). Perebih tonzyliarnoi infektsii ta zakhvoriuvan parodontu v svitli okremykh aspektiv etiolohii ta patohenezu (ohliad literatury). Visnyk problem biolohii i medytsyny, Vyp., 2, (2 (151)), 24–29. doi: 10.29254/2077-4214-2019-2-2-151-24-29.
9. Majekodunmi, S. O. (2015) A Review on Lozenges. American Journal of Medicine and Medical Sciences, 5 (2), 99–104. doi: 10.5923/j.ajmms.20150502.07.
10. Pundir, S. A., Varma, A. M. L. (2014). Review on lozenges. J. der Pharma. Forschung., Vol. 2 (1), 1–10.
11. Hordiienko, O. I., Hroshovyi, T. A. (2017). Farmatsevtychnyi chasopys, 1, 74–80. doi: 10.11603/2312-0967.2017.1.7556/.
12. Yankovskii, D. S. (2005). Mikrobnaia e`kolohiia cheloveka. Sovremenny`e vozmozhnosti ee podderzhaniia i vosstanovleniia. Kiev: E`kspert LTD, 362.
13. Kaliuzhnaia, O. S., Kaliuzhnyi, O. B. (2020). Tekhnichnyi servis ahropromyslovoho, lisovoho ta transportnoho kompleksiv, 22, 84–89.
Copyright (c) 2021 National University of Pharmacy
This work is licensed under a Creative Commons Attribution 4.0 International License.Authors who publish with this journal agree to the following terms:
- Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
- Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
- Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access).